@FrederickLangMD interview with Dr. Jim Allison on his Nobel prize winning work on CTLA4 checkpoint inhibitors that cure previously fatal cancers like melanoma. Inspirational work that gives us hope for curing the currently fatal GBM @UTMDAnderson@txbraintrust@AANSNeuro
Great presentation at Neurosurgery Grand Rounds by plastic surgeon Dr. Edward Chang on neurosurgical reconstruction. Interdisciplinary collaboration at @UTMDAnderson
powers our education program and brings the best care to our patients. #oncsurgery#endcancer
First succeesful Lab showing at AACR 2026, an oral presentation on translating spatial multiomics discoveries into better treatments for gliomas and a poster on FLASH radiotherapy for gliomas. Grateful for an amazing team and supportive collaborators @UTMDAnderson@txbraintrust
New data from UT MD Anderson researchers found that blocking both CD47 and CD24 proteins heightened the immunotherapy response in GBM models.
What's next for this approach: https://t.co/RgVp06QOkj @BettyKimLab#EndCancer
Four exceptional scientists have been appointed to the James P. Allison Institute at UT MD Anderson.
They bring expertise in immune therapy resistance, cancer vaccines, bioengineering, tumor evolution and drug development: https://t.co/h3vdWSF0tv #EndCancer@BettyKimLab@hojong_yoon
Neurosurgery Grand Rounds at @MDAndersonNews kicked off this morning with @HTawbi_MD, melanoma and brain metastasis expert. As usual, we had a full house; residents and fellows were engaged in discussion all morning! #oncsurgery#endcancer
The Broach Foundation exists to fund novel research advancing the prevention, treatment, and cure of brain cancer.
Brain cancer is an extraordinarily challenging disease.
Together we can find a cure for brain cancer! Join us!
#NoOneFightsAlone#endcancer#ResearchIsHope
Just published! 💫 In supratentorial high-grade gliomas, ventricle entry during resection did not increase leptomeningeal metastasis risk or worsen survival - tumor ependymal contact is the key driver.
@DrJeffWeinberg@txbraintrust@TheJNS
https://t.co/xrBhgdfJWX
MD Anderson researchers found that adding an immune booster to a cancer-targeting virus increased survival for some patients with glioblastoma and helped identify blood biomarkers in patients most likely to benefit: https://t.co/ddd1rdhyv9 @FrederickLangMD#EndCancer
Excited to welcome Dr. Hideho Okada of @UCSF to @MDAndersonNews yesterday! He presented his work on T-cell -based immunotherapy strategies for malignant gliomas to a large group of Brain Tumor Center researchers and students—Q&A went overtime!#oncsurgery#endcancer
“One of the best things about our job is that we get to see patients every day. They are our inspiration.”
-Dr. Michael Lim @stanfordnsurg at the @MDAndersonNews Leavens Lecture, “Overcoming the immune microenvironment in GBM.”#oncsurgery#endcancer
Dr. Chandra Sen addressed @MDAndersonNews trainees and faculty at the annual Skull Base Course today. The room was filled for his lecture, “Management of the Venous System in Skull Base Surgery. Great way to kick off 2026! #oncsurgery#endcancer
A beautiful Saturday celebrating the @MDAndersonNews Boot Walk in Cypress. Thank you to my Neurosurgery colleagues for a great morning honoring our loved ones who have faced cancer. #oncsurgery#endcancer
Registration is now open for the 2026 International Cancer Neuroscience Symposium. This three-day, hybrid event will feature key insights and the latest, cutting-edge research from over 30 leading international experts.
Learn more and register: https://t.co/d2bKQU9E3y #EndCancer
“I’m here to tell you what happens to the tumor after you resect it.”
@kcakdemir presented to Neurosurgery residents and fellows at @MDAndersonNews today. His lab analyzes tumor samples to advance efforts for precision cancer medicine and to #endcancer. #oncsurgery
Neurosurgery is #hiring! Join our award-winning nursing team at @MDAndersonNews!
We're seeking an exceptional APP to join our outpatient team. Those with skull base experience are particularly encouraged to apply.
Learn more 🔽
https://t.co/GurIbOTp7g
Inspirational talk today by Dr. Monje at our MD Anderson BTP CNP seminar fall series focused on pediatric neurooncology! We need more “out of the box” thinkers like Dr. Monje to help find a cure for malignant brain tumors which remain a fatal disease despite agressive treatments!
“Cancer neuroscience is emerging as a field.”
Dr. @michelle_monje presented on the #neuroscience of #braincancer to
more than 80 researchers at @MDAndersonNews today.
Learn more about how the Cancer Neuroscience Program is working to #endcancer. ⬇️
https://t.co/CmtmZ1TVMJ